This compound is a pharmaceutical intermediate featuring a tert-butyl carbamate protective group, a dibromo-substituted pyridine ring, and a difluorophenyl moiety. It is used in the synthesis of drug candidates, particularly those requiring stereochemically defined building blocks.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1620056-47-4
N-(3-Chloro-4-fluorophenyl)-7-fluoro-6-nitro-4-quinazolinamine
pharmaceutical intermediate
7-Fluoro-6-nitro-4-hydroxyquinazoline
pharmaceutical intermediate
4-Chloro-7-fluoro-6-nitroquinazoline
pharmaceutical intermediate
4-(Cyclopropylcarbonyl)-alpha,alpha-dimethylbenzeneacetic acid
pharmaceutical intermediate
Tert-Butyl (S)-(1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate
pharmaceutical intermediate
2-(1,2-dibromo-2-phenylethyl)pyridine
research compound
tert-butyl N-[(1S)-1-(3,6-dibromo-2-pyridinyl)-2-(3,5-difluorophenyl)ethyl]carbamate
XKLGEKSJSJYONN-AWEZNQCLSA-N
CC(C)(C)OC(=O)N[C@@H](CC1=CC(=CC(=C1)F)F)C2=C(C=CC(=N2)Br)Br
—